ESKAPEing the labyrinth of antibacterial discovery

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature reviews. Drug discovery

• Publication date

  2015-07-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/nrd4572PMID 26139286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toward the rational design of carbapenem uptake in Pseudomonas aeruginosa.

  2015cited by this paper
• Novel Antibacterial Targets and Compounds Revealed by a High-Throughput Cell Wall Reporter Assay

  2015cited by this paper
• Genome‐Wide Fitness and Genetic Interactions Determined by Tn‐seq, a High‐Throughput Massively Parallel Sequencing Method for Microorganisms

  2015cited by this paper
• A new antibiotic kills pathogens without detectable resistance

  2015cited by this paper
• Genes Contributing to Staphylococcus aureus Fitness in Abscess- and Infection-Related Ecologies

  2014cited by this paper
• Global transcriptional response of Acinetobacter baumannii to a subinhibitory concentration of tigecycline.

  2014cited by this paper
• Genome-Wide Mutant Fitness Profiling Identifies Nutritional Requirements for Optimal Growth of Yersinia pestis in Deep Tissue

  2014cited by this paper
• General Platform for Systematic Quantitative Evaluation of Small-Molecule Permeability in Bacteria

  2014cited by this paper
• Genome-Wide Identification of Acinetobacter baumannii Genes Necessary for Persistence in the Lung

  2014cited by this paper
• ChIP-Seq and RNA-Seq Reveal an AmrZ-Mediated Mechanism for Cyclic di-GMP Synthesis and Biofilm Development by Pseudomonas aeruginosa

  2014cited by this paper
• Genome‐Wide Fitness and Genetic Interactions Determined by Tn‐seq, a High‐Throughput Massively Parallel Sequencing Method for Microorganisms

  2014cited by this paper
• Drug development: Time for teamwork

  2014cited by this paper
• New natural products as new leads for antibacterial drug discovery.

  2014cited by this paper
• Comparative Systems Biology Analysis To Study the Mode of Action of the Isothiocyanate Compound Iberin on Pseudomonas aeruginosa

  2014cited by this paper
• Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC

  2014cited by this paper
• Siderophores as “Trojan Horses”: tackling multidrug resistance?

  2014cited by this paper
• Trends and exceptions of physical properties on antibacterial activity for Gram-positive and Gram-negative pathogens.

  2014cited by this paper
• Requirements for Pseudomonas aeruginosa Acute Burn and Chronic Surgical Wound Infection

  2014cited by this paper
• LC-MS based assay to measure intracellular compound levels in Mycobacterium smegmatis: linking compound levels to cellular potency.

  2013cited by this paper
• Discovery of Inhibitors of 4′-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for Antibacterial Therapy

  2013cited by this paper
• Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing

  2013cited by this paper
• 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America.

  2013cited by this paper
• Progress toward single cell metabolomics.

  2013cited by this paper
• Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

  2013cited by this paper
• Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria

  2013cited by this paper
• Toward Understanding the Outer Membrane Uptake of Small Molecules by Pseudomonas aeruginosa*

  2013cited by this paper
• Siderophore conjugates

  2013cited by this paper
• Genome-Wide Detection of Fitness Genes in Uropathogenic Escherichia coli during Systemic Infection

  2013cited by this paper
• Microbiology and proteomics, getting the best of both worlds!

  2013cited by this paper
• Novel topoisomerase inhibitors: microbiological characterisation and in vivo efficacy of pyrimidines.

  2013cited by this paper
• Substrate Specificity within a Family of Outer Membrane Carboxylate Channels

  2012cited by this paper
• A kinetic Monte Carlo approach to investigate antibiotic translocation through bacterial porins

  2012cited by this paper
• A metabolic network approach for the identification and prioritization of antimicrobial drug targets.

  2012cited by this paper
• In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compound.

  2012cited by this paper
• In Vitro and In Vivo Properties of BAL30376, a β-Lactam and Dual β-Lactamase Inhibitor Combination with Enhanced Activity against Gram-Negative Bacilli That Express Multiple β-Lactamases

  2011cited by this paper
• In Vitro Validation of Acetyltransferase Activity of GlmU as an Antibacterial Target in Haemophilus influenzae*

  2011cited by this paper
• Genome-Scale Identification of Resistance Functions in Pseudomonas aeruginosa Using Tn-seq

  2011cited by this paper
• Molecular obesity, potency and other addictions in drug discovery

  2011cited by this paper
• Bugs, drugs and chemical genomics.

  2011cited by this paper
• Novel Bacterial NAD+-Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy In Vivo

  2010cited by this paper
• Atomic-Level Characterization of the Structural Dynamics of Proteins

  2010cited by this paper
• The bacterial cell envelope.

  2010cited by this paper
• Siderophores as drug delivery agents: application of the “Trojan Horse” strategy

  2009cited by this paper
• Aligning antimicrobial drug discovery with complex and redundant host-pathogen interactions.

  2009cited by this paper
• Physicochemical properties of antibacterial compounds: implications for drug discovery.

  2008cited by this paper
• Structural insight into OprD substrate specificity

  2007cited by this paper
• The influence of drug-like concepts on decision-making in medicinal chemistry

  2007cited by this paper
• Drugs for bad bugs: confronting the challenges of antibacterial discovery

  2007cited by this paper
• Synthesis of pyochelin-norfloxacin conjugates.

  2007cited by this paper
• Involvement of two related porins, OprD and OpdP, in the uptake of arginine by Pseudomonas aeruginosa.

  2006cited by this paper
• hERG potassium channels and cardiac arrhythmia

  2006cited by this paper
• Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.

  2005cited by this paper
• Bacterial cell shape

  2005cited by this paper
• Assessment of the consistency of medicinal chemists in reviewing sets of compounds.

  2004cited by this paper
• Fragment-based lead discovery

  2004cited by this paper
• Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones.

  2003cited by this paper
• Identification and prediction of promiscuous aggregating inhibitors among known drugs.

  2003cited by this paper
• A comparison of physiochemical property profiles of development and marketed oral drugs.

  2003cited by this paper
• Function of pseudomonas porins in uptake and efflux.

  2002cited by this paper
• Escaping free-energy minima

  2002cited by this paper
• Cellular impermeability and uptake of biocides and antibiotics in Gram‐negative bacteria

  2002cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Accumulation of rifampicin by Escherichia coli and Staphylococcus aureus.

  1998cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

  1990cited by this paper
• Time for teamwork.

  1974cited by this paper
• Annals of the New York Academy of Sciences the Evolution of the Regulatory Framework for Antibacterial Agents

  year unknowncited by this paper
• Edinburgh Research Explorer Genome-wide saturation mutagenesis of Burkholderia pseudomallei K96243 predicts essential genes and novel targets for antimicrobial development

  year unknowncited by this paper

• Discovery and Development of Antibacterial Peptidoglycan Hydrolase Inhibitors.

  2026cites this paper
• Biofilm Formation in Clinical Acinetobacter baumannii Is Influenced by Isolate Source and Is Inversely Correlated With Antibiotic Resistance

  2026cites this paper
• Circumnavigating Antibiotic Mechanisms of Action and Resistance Research.

  2026cites this paper
• Genome editing of phylogenetically distinct bacteria using portable retron-mediated recombineering

  2025cites this paper
• Broadening the scope of Bacteria DNA Gyrase B Inhibitors by marine compounds: insights form molecular docking, MM-GBSA, molecular dynamics simulations and ADMET predictions

  2025cites this paper
• A three-dimensional high throughput assay identifies novel antibacterial molecules with activity against intracellular Shigella

  2025cites this paper
• Improved Free-Energy Estimates for the Permeation of Bulky Antibiotic Molecules through Porin Channels Using Temperature-Accelerated Sliced Sampling

  2025cites this paper
• Carrier-mediated transport as a common route of antibiotic ingress into bacteria

  2025cites this paper
• Host DNA damage and cellular fate in bacterial infections, with a focus on Staphylococcus aureus.

  2025cites this paper
• Structurally Engineered SO2-Releasing Polymeric Nanoassembly for Broad-Spectrum Antibacterial Activity.

  2025cites this paper
• Synthesis and active evaluation of LecB-targeted cyclic dipeptide quorum sensing inhibitors

  2025cites this paper
• Engineering Endolysins for Enhanced Bacteriolytic Activity Using Genetically Encoded Azido-Containing Noncanonical Amino Acids.

  2025cites this paper
• Rational design of ivacaftor-derived antimicrobial peptidomimetics: Membrane-targeting strategy enhances broad-spectrum antimicrobial efficacy against MDR pathogens.

  2025cites this paper
• AI-guided Antibiotic Discovery Pipeline from Target Selection to Compound Identification

  2025cites this paper
• Self-Assembling Cyclic Peptide Nanotubes for the Delivery of Doxorubicin into Drug-Resistant Cancer Cells

  2025cites this paper
• Dual-action thioarylamide-based small molecules to target drug-resistant bacteria and chronic inflammation

  2025cites this paper
• Catalyzing Change: Entrepreneurs from the Global South Leading the Fight against Antimicrobial Resistance.

  2025cites this paper
• Thiazolyl Benzenesulfonamide Derivative as a Novel Inhibitor of Thymidine Kinase: Promising Therapeutics Against Staphylococcus aureus

  2025cites this paper
• Insights into the effects of haze pollution on airborne bacterial communities and antibiotic resistance genes in fine particulate matter.

  2025cites this paper
• Insight into the Mechanism of Action of Prokaryotic SSB Interactomes.

  2025cites this paper
• Development of Pyrimido Pyridazine Analogs through Increased Whole Cell Target Engagement of the Dihydropteroate Synthase Pterin Binding Site in Gram-Negative Bacteria

  2025cites this paper
• Natural sideromycins and siderophore-conjugated natural products as inspiration for novel antimicrobial agents.

  2025cites this paper
• Assessing the Mechanism of Action of Synthetic Nanoengineered Antimicrobial Polymers against the Bacterial Membrane of Pseudomonas aeruginosa

  2025cites this paper
• Cell-free synthetic biology for natural product biosynthesis and discovery

  2025cites this paper
• Negamycin: Nature’s Forgotten Antibiotic

  2025cites this paper
• Understanding Compound Efflux from Gram-Negative Bacteria, a Final Frontier for Antibiotic Discovery.

  2025cites this paper
• Molecular detection of phenol-soluble modulin-mec (PSM-mec) in Staphylococcus aureus clinical isolates from Federal Medical Center Birnin Kebbi, North-West, Nigeria

  2025cites this paper
• Global health perspectives on antibacterial drug discovery and the preclinical pipeline

  2025cites this paper
• Revolutionizing gastroenterology and hepatology with artificial intelligence: From precision diagnosis to equitable healthcare through interdisciplinary practice

  2025cites this paper
• Depth-Resolved Temperature-Dependent Penetration of Polymyxin B in Phospholipids/Lipopolysaccharide Asymmetric Bilayers

  2025cites this paper
• Identification of drug targets in pan-drug resistant Acinetobacter baumannii via whole genome sequencing and subtractive genomics

  2025cites this paper
• A host defense peptide-mimicking prodrug activated by drug-resistant Gram-negative bacterial infections.

  2025cites this paper
• Measurement and prediction of small molecule retention by Gram-negative bacteria based on a large-scale LC/MS screen

  2025cites this paper
• Advances in structural modification of natural products with antimicrobial activity.

  2025cites this paper
• Challenges and opportunities in nanotherapeutics targeted for central nervous system disorders.

  2025cites this paper
• The role of Acinetobacter baumannii in infectious pathology (literature review)

  2025cites this paper
• Transfer learning enables discovery of sub-micromolar antibacterials for ESKAPE pathogens from ultra-large chemical spaces

  2025cites this paper
• Proteomic Insights into Bacterial Responses to Antibiotics: A Narrative Review

  2025cites this paper
• [Infectious diseases in 2025 Vulnerable populations, diagnostic and therapeutic challenges].

  2025cites this paper
• Antibiotics re-booted—time to kick back against drug resistance

  2025influential citation
• Amino Acid-Conjugated Polymer-Silver Bromide Nanocomposites for Eradicating Polymicrobial Biofilms and Treating Burn Wound Infections.

  2024cites this paper
• The antibiotic resistance crisis and the development of new antibiotics

  2024cites this paper
• Integrating bacterial molecular genetics with chemical biology for renewed antibacterial drug discovery

  2024cites this paper
• Structural insights into the transporting and catalyzing mechanism of DltB in LTA D-alanylation

  2024cites this paper
• Intracellular Quantification of an Antibiotic Metal Complex in Single Cells of Escherichia coli Using Cryo-X-ray Fluorescence Nanoimaging

  2024cites this paper
• Exploring Novel Antibiotics by Targeting the GroEL/GroES Chaperonin System

  2024cites this paper
• Pan-genome analysis and drug repurposing strategies for extensively drug-resistant Salmonella Typhi: Subtractive genomics and e-pharmacophore approaches.

  2024cites this paper
• Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research

  2024cites this paper
• Beyond Antibiotics: What the Future Holds

  2024cites this paper
• Anti-Skin Aging Potential, Antibacterial Activity, Inhibition of Single-Stranded DNA-Binding Protein, and Cytotoxic Effects of Acetone-Extracted Passiflora edulis (Tainung No. 1) Rind Extract on Oral Carcinoma Cells

  2024cites this paper
• Optimization of Screening Media to Improve Antimicrobial Biodiscovery from Soils in Undergraduate/Citizen Science Research-Engaged Initiatives

  2024cites this paper
• Identification of cell wall binding domains and repeats in Streptococcus pneumoniae phage endolysins: A molecular and diversity analysis

  2024cites this paper
• Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic ß-lactams as inhibitors of penicillin-binding protein(s)

  2024cites this paper
• Dual Antibiotic Approach: Synthesis and Antibacterial Activity of Antibiotic–Antimicrobial Peptide Conjugates

  2024cites this paper
• Discovery of GuaB inhibitors with efficacy against Acinetobacter baumannii infection

  2024cites this paper
• Sophisticated natural products as antibiotics

  2024cites this paper
• Single Amine or Guanidine Modification on Norvancomycin and Vancomycin to Overcome Multidrug-Resistance through Augmented Lipid II Binding and Increased Membrane Activity.

  2024cites this paper
• Machine Learning Prediction of Small Molecule Accumulation in Escherichia Coli Enhanced with Descriptor Statistics.

  2024cites this paper
• Antibacterial Potential of Dewandaru Leaves (Eugenia uniflora L.) Against Escherichia coli: In Vitro Study

  2024cites this paper
• A Review of Antibacterial Candidates with New Modes of Action

  2024cites this paper
• Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase

  2024cites this paper
• Förster Resonance Energy Transfer Measurements in Living Bacteria for Interaction Studies of BamA with BamD and Inhibitor Identification

  2024cites this paper
• Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria

  2024cites this paper
• Evaluation of Fusobacterium nucleatum Enoyl-ACP Reductase (FabK) as a Narrow-Spectrum Drug Target

  2024cites this paper
• Overcoming Therapeutic Challenges of Antibiotic Delivery with Cubosome Lipid Nanocarriers.

  2024cites this paper
• Sepsis, Antimicrobial Resistance, and Alternative Therapies

  2024cites this paper
• Antimicrobial Indole-3-Carboxamido-Polyamine Conjugates Target Bacterial Membranes and Are Antibiotic Potentiators

  2024cites this paper
• Recent advances in the exploration of oxazolidinone scaffolds from compound development to antibacterial agents and other bioactivities.

  2024cites this paper
• Beyond Antibiotics: Cinnamic Acid’s role in combatting complex biofilms in the oral cavity

  2024cites this paper
• Multidrug efflux in Gram-negative bacteria: structural modifications in active compounds leading to efflux pump avoidance

  2024cites this paper
• Cell envelope structural and functional contributions to antibiotic resistance in Burkholderia cenocepacia

  2024cites this paper
• Important challenges to finding new leads for new antibiotics.

  2024cites this paper
• High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae

  2024cites this paper
• Discovery of a Pseudomonas aeruginosa-specific small molecule targeting outer membrane protein OprH-LPS interaction by a multiplexed screen.

  2024cites this paper
• Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.

  2024cites this paper
• History of the streptothricin antibiotics and evidence for the neglect of the streptothricin resistome

  2024cites this paper
• Using permeation guidelines to design new antibiotics—A PASsagE into Pseudomonas aeruginosa

  2024cites this paper
• Pre-trained molecular representations enable antimicrobial discovery

  2024cites this paper
• Соціально-культурні проєкти як важливий чинник адаптації внутрішньо переміщених осіб та розвитку соціального підприємництва в умовах російсько-української війни

  2023cites this paper
• Today’s drug discovery and the shadow of the rule of 5

  2023cites this paper
• Multidrug Efflux in Gram-Negative Bacteria: Rationally Modifying Compounds to Avoid Efflux Pumps

  2023cites this paper
• The Inhibitory Effects and Cytotoxic Activities of the Stem Extract of Nepenthes miranda against Single-Stranded DNA-Binding Protein and Oral Carcinoma Cells

  2023cites this paper
• Bio-inspired peptide-conjugated liposomes for enhanced planktonic bacteria killing and biofilm eradication.

  2023cites this paper
• Novel resveratrol derivatives as potent membrane-active antibacterial agents

  2023cites this paper
• Inhibition of Multidrug Efflux Pumps Belonging to the Major Facilitator Superfamily in Bacterial Pathogens

  2023cites this paper
• Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii

  2023influential citation
• Inteligencia artificial en enfermedades infecciosas

  2023cites this paper
• Antimicrobial Resistance: Two-Component Regulatory Systems and Multidrug Efflux Pumps

  2023cites this paper
• Current Clinical Landscape and Global Potential of Bacteriophage Therapy

  2023cites this paper
• Gallic Acid Restores the Sulfonamide Sensitivity of Multidrug-Resistant Streptococcus suis via Polypharmaceology Mechanism.

  2023cites this paper
• Transcriptomic and metabolomic characterization of antibacterial activity of Melastoma dodecandrum

  2023cites this paper
• Food for thought: Opportunities to target carbon metabolism in antibacterial drug discovery

  2023cites this paper
• Fast Prediction of Antibiotic Permeability through Membrane Channels using Brownian Dynamics.

  2023cites this paper
• On Finding Natural Antibiotics based on TCM Formulae.

  2023cites this paper
• Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors.

  2023cites this paper
• Bacterial Outer-Membrane-Mimicking Giant Unilamellar Vesicle Model for Detecting Antimicrobial Permeability.

  2023cites this paper
• Structural Adaptation of the Single-Stranded DNA-Binding Protein C-Terminal to DNA Metabolizing Partners Guides Inhibitor Design

  2023cites this paper
• Cell selectivity and antibiofilm and anti-inflammatory activities and antibacterial mechanism of symmetric-end antimicrobial peptide centered on D-Pro-Pro.

  2023cites this paper
• Identification and structure-activity relationships for a series of N, N-disubstituted 2-aminobenzothiazoles as potent inhibitors of S. aureus.

  2023cites this paper
• Chemical Basis of Combination Therapy to Combat Antibiotic Resistance

  2023cites this paper